Biotechnology companies can use “value-chain analysis” to create processes for maximizing the value of their intellectual property portfolios, say Bill Barrett and Dave Crawford. Every ...

Let’s dig into the relative performance of Fortrea (NASDAQ:FTRE) and its peers as we unravel the now-completed Q4 drug development inputs & services earnings season. Companies specializing in drug ...

Companies specializing in drug development inputs and services play a crucial role in the pharmaceutical and biotechnology value chain. Essential support for drug discovery, preclinical testing ...